vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与RAYONIER INC（RYN）财务数据对比。点击上方公司名可切换其他公司
RAYONIER INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$117.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -81.9%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Rayonier Inc.是总部位于佛罗里达州怀尔德莱特的林地房地产投资信托（REIT），资产分布在美国和新西兰的软木种植区域，核心业务板块为木材业务与房地产业务。
PBYI vs RYN — 直观对比
营收规模更大
RYN
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出109.7%
-81.9%
两年增速更快
PBYI
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $117.5M |
| 净利润 | — | $25.9M |
| 毛利率 | 69.3% | 41.9% |
| 营业利润率 | 22.7% | 23.0% |
| 净利率 | — | 22.1% |
| 营收同比 | 27.7% | -81.9% |
| 净利润同比 | — | -92.1% |
| 每股收益（稀释后） | $0.26 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRYN
| Q4 25 | $75.5M | $117.5M | ||
| Q3 25 | $54.5M | $177.5M | ||
| Q2 25 | $52.4M | $106.5M | ||
| Q1 25 | $46.0M | $82.9M | ||
| Q4 24 | $59.1M | $650.5M | ||
| Q3 24 | $80.5M | $124.1M | ||
| Q2 24 | $47.1M | $99.6M | ||
| Q1 24 | $43.8M | $113.7M |
净利润PBYIRYN
| Q4 25 | — | $25.9M | ||
| Q3 25 | $8.8M | $43.2M | ||
| Q2 25 | $5.9M | $408.7M | ||
| Q1 25 | $3.0M | $-3.4M | ||
| Q4 24 | — | $327.1M | ||
| Q3 24 | $20.3M | $28.8M | ||
| Q2 24 | $-4.5M | $1.9M | ||
| Q1 24 | $-4.8M | $1.4M |
毛利率PBYIRYN
| Q4 25 | 69.3% | 41.9% | ||
| Q3 25 | 77.7% | 32.9% | ||
| Q2 25 | 76.5% | 29.7% | ||
| Q1 25 | 77.1% | 21.7% | ||
| Q4 24 | 76.4% | 53.8% | ||
| Q3 24 | 63.9% | 30.4% | ||
| Q2 24 | 77.4% | 25.4% | ||
| Q1 24 | 75.5% | 24.3% |
营业利润率PBYIRYN
| Q4 25 | 22.7% | 23.0% | ||
| Q3 25 | 17.6% | 23.5% | ||
| Q2 25 | 12.7% | 13.7% | ||
| Q1 25 | 8.7% | 0.1% | ||
| Q4 24 | 22.6% | 47.7% | ||
| Q3 24 | 27.4% | 15.2% | ||
| Q2 24 | -4.6% | 4.6% | ||
| Q1 24 | -5.3% | 7.6% |
净利率PBYIRYN
| Q4 25 | — | 22.1% | ||
| Q3 25 | 16.2% | 24.3% | ||
| Q2 25 | 11.2% | 383.6% | ||
| Q1 25 | 6.5% | -4.1% | ||
| Q4 24 | — | 45.1% | ||
| Q3 24 | 25.2% | 23.2% | ||
| Q2 24 | -9.6% | 1.9% | ||
| Q1 24 | -11.0% | 1.2% |
每股收益（稀释后）PBYIRYN
| Q4 25 | $0.26 | $0.14 | ||
| Q3 25 | $0.17 | $0.28 | ||
| Q2 25 | $0.12 | $2.63 | ||
| Q1 25 | $0.06 | $-0.02 | ||
| Q4 24 | $0.40 | $2.18 | ||
| Q3 24 | $0.41 | $0.19 | ||
| Q2 24 | $-0.09 | $0.01 | ||
| Q1 24 | $-0.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $842.9M |
| 总债务越低越好 | $22.7M | $845.3M |
| 股东权益账面价值 | $130.3M | $2.2B |
| 总资产 | $216.3M | $3.4B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.38× |
8季度趋势，按日历期对齐
现金及短期投资PBYIRYN
| Q4 25 | $97.5M | $842.9M | ||
| Q3 25 | $94.4M | $919.6M | ||
| Q2 25 | $96.0M | $892.3M | ||
| Q1 25 | $93.2M | $216.2M | ||
| Q4 24 | $101.0M | $303.1M | ||
| Q3 24 | $96.7M | $51.9M | ||
| Q2 24 | $96.8M | $120.2M | ||
| Q1 24 | $107.2M | $142.1M |
总债务PBYIRYN
| Q4 25 | $22.7M | $845.3M | ||
| Q3 25 | $34.0M | $845.1M | ||
| Q2 25 | $45.3M | $844.9M | ||
| Q1 25 | $56.7M | $1.0B | ||
| Q4 24 | $68.0M | $1.0B | ||
| Q3 24 | $79.3M | $1.3B | ||
| Q2 24 | $90.7M | $1.4B | ||
| Q1 24 | $102.0M | $1.4B |
股东权益PBYIRYN
| Q4 25 | $130.3M | $2.2B | ||
| Q3 25 | $115.3M | $2.3B | ||
| Q2 25 | $104.7M | $2.3B | ||
| Q1 25 | $97.1M | $1.9B | ||
| Q4 24 | $92.1M | $1.8B | ||
| Q3 24 | $71.1M | $1.8B | ||
| Q2 24 | $48.5M | $1.8B | ||
| Q1 24 | $51.0M | $1.8B |
总资产PBYIRYN
| Q4 25 | $216.3M | $3.4B | ||
| Q3 25 | $202.9M | $3.5B | ||
| Q2 25 | $194.9M | $3.5B | ||
| Q1 25 | $196.2M | $3.4B | ||
| Q4 24 | $213.3M | $3.5B | ||
| Q3 24 | $220.7M | $3.5B | ||
| Q2 24 | $205.0M | $3.5B | ||
| Q1 24 | $214.1M | $3.6B |
负债/权益比PBYIRYN
| Q4 25 | 0.17× | 0.38× | ||
| Q3 25 | 0.30× | 0.37× | ||
| Q2 25 | 0.43× | 0.37× | ||
| Q1 25 | 0.58× | 0.55× | ||
| Q4 24 | 0.74× | 0.59× | ||
| Q3 24 | 1.12× | 0.72× | ||
| Q2 24 | 1.87× | 0.75× | ||
| Q1 24 | 2.00× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $256.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 9.91× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIRYN
| Q4 25 | $14.4M | $256.7M | ||
| Q3 25 | $9.7M | $116.2M | ||
| Q2 25 | $14.1M | $61.0M | ||
| Q1 25 | $3.6M | $27.7M | ||
| Q4 24 | $15.6M | $261.6M | ||
| Q3 24 | $11.0M | $66.2M | ||
| Q2 24 | $1.0M | $55.3M | ||
| Q1 24 | $11.2M | $52.3M |
自由现金流PBYIRYN
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | $99.9M | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | $42.2M | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIRYN
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | 56.3% | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | 34.0% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIRYN
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 9.2% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 19.3% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIRYN
| Q4 25 | — | 9.91× | ||
| Q3 25 | 1.10× | 2.69× | ||
| Q2 25 | 2.41× | 0.15× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 0.80× | ||
| Q3 24 | 0.54× | 2.30× | ||
| Q2 24 | — | 29.07× | ||
| Q1 24 | — | 38.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
RYN
| Real Estate Segment | $42.3M | 36% |
| Pacific Northwest Timber Segment | $19.8M | 17% |
| Stumpage Pay As Cut | $19.3M | 16% |
| Improved Development | $14.8M | 13% |
| Nontimber | $13.2M | 11% |
| License Revenue Primarily From Hunting | $5.3M | 4% |
| Land Based Solutions | $2.9M | 2% |
